Your session is about to expire
← Back to Search
MDMA-Assisted Therapy for PTSD (MPVA6 Trial)
MPVA6 Trial Summary
This trial will compare the effectiveness of 2 vs 3 sessions of MDMA-assisted therapy in treating PTSD in US military veterans.
MPVA6 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMPVA6 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MPVA6 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had low sodium levels or very high body temperature in the past.You are not participating in any other interventional clinical trials during the duration of the study.I am 18 years old or older.You have a history of serious medical conditions or currently have a significant medical problem.I have symptoms caused by liver problems.I can swallow pills.I have been diagnosed with moderate PTSD.I am not pregnant, nursing, or if capable of becoming pregnant, I am using effective birth control.I can fluently speak and read the main language used at the study site.I can swallow pills.I have been diagnosed with moderate PTSD.I can fluently speak and read the main language used at the study site.I am 18 years old or older.I agree to stay overnight at the study site and follow all study procedures.Must provide a contact (relative, spouse, close friend or other caregiver) who is willing and able to be reached by the investigators in the event of a participant becoming suicidal or unreachable.My high blood pressure is not under control.I weigh less than 48 kg.I am unable to understand or sign the consent form.You agree to have study visits recorded, including Experimental Sessions, Independent Rater assessments, and non-drug psychotherapy sessions.I have risk factors for a specific heart rhythm issue (like heart failure or low potassium).
- Group 1: Two sessions of MDMA-assisted therapy
- Group 2: Three sessions of MDMA-assisted therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies left in the experiment for participants?
"Affirmative. According to the clinicaltrials.gov website, enlistment for this medical trial is still open after its initial posting on November 8th 2021 and subsequent update made on September 13th 2022. For completion of the study, 60 participants will be sought from a single site."
What is the aggregate number of participants enrolled in this clinical investigation?
"Affirmative. According to the clinicaltrials.gov, this medical trial is currently in recruitment mode and has been since November 8th 2021. The latest update was posted on September 13th 2022 and it requires 60 volunteers from a single location."
To what extent are Three MDMA-assisted Psychotherapy Sessions potentially harmful to the patient?
"Our team at Power has assigned Three MDMA-assisted Psychotherapy Sessions a safety rating of 2, as this is considered to be in the second phase of clinical trials. Thus far, there are data points that hint towards its security but no evidence supporting efficacy."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger